What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 2 minute read Pharma Industry News Edgewise Therapeutics initiates EDG-7500 Phase 1 trial targeting cardiac diseases Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a biopharmaceutical company specializing in muscle diseases, announced the commencement of its Phase… byPallavi MadhirajuSeptember 14, 2023